Natural health product · DIN 02240501
M3
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed October 20, 2009.
- DIN
- 02240501
- Licence holder
- Future Formulations Inc.Scarborough, Ontario, Canada
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Transitional DIN
- First licensed
- October 20, 2009
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Lipase | 2,250 fcc units | Aspergillus niger |
| Lipase | 2,250 fcc units | Rhizopus Javanicus |
| Amylase | 6,000 fcc units | Aspergillus oryzae |
| Amylase | 6,000 fcc units | Aspergillus niger |
| Invertase | 10 fcc units | Saccharomyces sp. |
| Cellulase | 85 fcc units | Aspergillus niger |
| Cellulase | 85 fcc units | T. ressi |
| Lactase | 130 fcc units | Saccharomyces sp. |
| Lactase | 130 fcc units | Aspergillus oryzae |
| Maltase | 140 fcc units | Hordeum vulgare |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Digestive aid.
Non-medicinal ingredients
Gelatin; Purified water; Magnesium Stearate